Human immunodeficiency virus 1 dual-target nucleic acid technology improves blood safety: 5 years of experience of the German Red Cross blood donor service Baden-Württemberg-Hessen.

导出 LinkOut

翻译打印收藏纠错

作者： Kai,Hourfar ^[1] ; Josef,Eberle ^[2] ; Markus,Müller ^[1] ; C,Micha Nübling ^[3] ; Michael,Chudy ^[3] ; Julia,Kress ^[3] ; Lutz,Gürtler ^[2] ; Uschi,Mayr-Wohlfart ^[4] ; Hubert,Schrezenmeier ^[4] ; Inke,Hellmann ^[5] ; Jürgen,Luhm ^[5] ; Sabine,Kraas ^[5] ; Jürgen,Ringwald ^[5] ; Knut,Gubbe ^[6] ; Kerstin,Frank ^[6] ; Andreas,Karl ^[6] ; Torsten,Tonn ^[7] ; Maike,Jaeger ^[1] ; Walid,Sireis ^[1] ; Erhard,Seifried ^[1] ; Michael,Schmidt ^[1]

作者单位： German Red Cross Blood Donor Service Baden-Württemberg-Hessen, Institute for Transfusion Medicine and Immunohematology, Frankfurt, Germany. ^[1] Virology, National Reference Center for Retroviruses, Faculty of Medicine, Max von Pettenkofer Institute and Gene Center, LMU München, Munich, Germany. ^[2] Paul-Ehrlich-Institut, Langen, Germany. ^[3] Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Ulm, Germany. ^[4] German Red Cross Blood Donor Service North-East, Institute Lütjensee, Lütjensee, Germany. ^[5] German Red Cross Blood Donor Service North-East, Institute Plauen, Plauen, Germany. ^[6] German Red Cross Blood Donor Service North-East, Institute Dresden, Dresden, Germany. ^[7]